Clinical Trial Update: Intestinal Microbiome-based Research for the Prevention of Acute GVHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intestinal microbiome-based approaches (postbiotics/butyrate) to prevent acute graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Graft Versus Host Disease, Postbiotics | Phase 2 | Status: UNKNOWN